A scoping review shows machine learning models may help predict response to biologic and targeted synthetic DMARDs in ...

J&J, ImmunityBio and Foghorn Therapeutics stand out as oncology players amid rapid innovation in cancer care with advancing pipelines, approvals and partnerships.

Precision medicine has revolutionized the landscape of neurological care, shifting from “one-size-fits-all” approaches to ...

The global market for Gastrointestinal Diagnostics was valued at US$4.9 Billion in 2024 and is projected to reach US$5.8 Billion by 2030, growing at a CAGR of 2.8% from 2024 to 2030. This ...

While the potential benefits of AI in obesity prevention are substantial, the study devotes significant attention to ...